Selective occlusion of subfoveal choroidal neovascularization in pathologic myopia using a new technique of ingrowth site treatment

American Journal of Ophthalmology

Volumn 135, Issue 6, 2003, Pages 857-866

  Costa, Rogério Alves ^a,b,c   Calucci, Daniela ^a   Teixeira, Luiz F ^a   Cardillo, Jose A ^a,b   Bonomo, Pedro P ^a  

^a FEDERAL UNIVERSITY OF SÃO PAULO   (Brazil)

^b Consultores de Retina e Associados ^*  (Brazil)

^c NONE   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

BENZOPORPHYRIN DERIVATIVE;

ADULT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; EVALUATION; EYE PROTECTION; FEMALE; FOLLOW UP; HEMOPERFUSION; HUMAN; INDOCYANINE GREEN ANGIOGRAPHY; LOW LEVEL LASER THERAPY; MALE; MEDICAL ASSESSMENT; MEDICAL EXAMINATION; MYOPIA; OPTICAL COHERENCE TOMOGRAPHY; PATIENT REFERRAL; PHOTODYNAMIC THERAPY; PRIORITY JOURNAL; RETINA EDEMA; SUBRETINAL NEOVASCULARIZATION; TREATMENT OUTCOME; VISUAL ACUITY;

EID: 0038281070     PISSN: 00029394     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9394(02)02257-2     Document Type: Article

References (27)

1. Photodynamic therapy of subfoveal choroidal neovascularization in pathologic myopia with verteporfin. 1-year results of a randomized clinical trial - VIP report no. 1. Ophthalmology. 108:2001;841-852.
2. Cohen S.Y., Laroche A., Leguen Y., Soubrane G., Coscas G.J. Etiology of choroidal neovascularization in young patients. Ophthalmology. 103:1996;1241-1244.
3. Avila M.P., Weiter J.J., Jalkh A.E., et al. Natural history of choroidal neovascularization in degenerative myopia. Ophthalmology. 91:1984;1573-1581.
4. Yoshida T., Ohno-Matsui K., Ohtake Y., et al. Long-term visual prognosis of choroidal neovascularization in high myopia. Ophthalmology. 109:2002;712-719.
5. Thomas M.A., Dickinson J.D., Melberg N.S., et al. Visual results after surgical removal of subfoveal choroidal neovascular membranes. Ophthalmology. 101:1994;1384-1396.
6. Bottoni F., Airaghi P., Perego E., et al. Surgical removal of idiopathic, myopic, and age-related subfoveal neovascularization. Graefes Arch Clin Exp Ophthalmol. 234:(Suppl 1):1996;S42-S50.
7. Fujikado T., Ohji M., Hayashi A., Kusaka S., Tano Y. Anatomic and functional recovery of the fovea after foveal translocation surgery without large retinotomy and simultaneous excision of a neovascular membrane. Am J Ophthalmol. 126:1998;839-842.
8. Fujii G.Y., Humayun M.S., Pieramici D.J., et al. Initial experience of inferior limited macular translocation for subfoveal choroidal neovascularization resulting from causes other than age-related macular degeneration. Am J Ophthalmol. 131:2001;90-100.
9. Hamelin N., Glacet-Bernard A., Brindeau C., et al. Surgical treatment of subfoveal neovascularization in myopia macular translocation versus surgical removal. Am J Ophthalmol. 133:2002;530-536.
10. Shiraga F., Ojima Y., Matsuo T., et al. Feeder vessel photocoagulation of subfoveal choroidal neovascularization secondary to age-related macular degeneration. Ophthalmology. 105:1998;662-669.
11. Staurenghi G., Orzalesi N., La Capria A., Aschero M. Laser treatment of feeder vessels in subfoveal choroidal neovascular membranes. Ophthalmology. 105:1998;2297-2305.
12. Costa R.A., Farah M.E., Freymuller E., et al. Choriocapillaris photodynamic therapy using indocyanine green. Am J Ophthalmol. 132:2001;557-565.
13. Costa R.A., Farah M.E., Cardillo J.A., Belfort R. Jr. Photodynamic therapy with indocyanine green for occult subfoveal choroidal neovascularization caused by age related macular degeneration. Curr Eye Res. 23:2001;271-275.
14. Melberg N.S., Thomas M.A., Burgess D.B. The surgical removal of subfoveal choroidal neovascularization. Ingrowth site as a predictor of visual outcome. Retina. 16:1996;190-195.
15. Shiraga F., Shiragama C., Matsuo T., et al. Identification of ingrowth site of idiopathic subfoveal choroidal neovascularization by indocyanine green angiography. Ophthalmology. 107:2000;600-607.
16. Costa RA, Calucci D, Cardillo JA, Farah ME. Selective occlusion of subfoveal choroidal neovascularization in angioid streaks using a new technique of ingrowth site treatment. Ophthalmology 2003; forthcoming.
17. Curtin B.J. The myopias: basic science and clinical management. 1985;7-10 Harper & Row, Philadelphia.
18. Curtin B.J., Karlin D.B. Axial length measurements and fundus changes of the myopic eye. Am J Ophthalmol. 71:1971;42-50.
19. Grossniklaus H.E., Green W.R. Pathologic findings in pathologic myopia. Retina. 12:1992;127-133.
20. Levy J.H., Pollock H.M., Curtin B.J. The Fuchs' spot an ophthalmoscopic and fluorescein angiographic study. Ann Ophthalmol. 9:1977;1433-1443.
21. Hotchkiss M.L., Fine S.L. Pathologic myopia and choroidal neovascularization. Am J Ophthalmol. 91:1981;177-183.
22. Hampton G.R., Kohen D., Bird A.C. Visual prognosis of disciform degeneration in myopia. Ophthalmology. 90:1983;923-926.
23. Flower R.W. Variability in choriocapillaris blood flow distribution. Invest Ophthalmol Vis Sci. 36:1995;1247-1258.
24. Flower R.W. Experimental studies of indocyanine green dye-enhanced photocoagulation of choroidal neovascularization feeder vessels. Am J Ophthalmol. 129:2000;501-512.
25. Flower R.W. Optimizing AMD-related CNV feeder vessel treatment. Am J Ophthalmol. 134:2002;228-239.
26. Mainster M.A., Reichel E. Transpupillary thermotherapy for age-related macular degeneration long-pulse photocoagulation, apoptosis, and heat shock proteins. Ophthalmic Surg Lasers. 31:2000;359-373.
27. Staurenghi G., Flower R. Clinical observations supporting a theoretical model of the role of choriocapillaris blood flow in treatment of AMD-associated CNV. Am J Ophthalmol. 133:2002;801-808.